Clinical Fellowship Reports 2020
We are extremely proud to announce that the EAN Congress has been named Best Corporate Event Subject to a Fee for the second consecutive year at the Evento Awards in Finland.
Latest Posts
-
-
Other News
EMA public stakeholders meeting on the approval, safety monitoring and impact of COVID-19 vaccines in the EU
March 1, 2021We would like to inform you of the third EMA public stakeholder meeting on the approval, safety monitoring and impact of COVID-19 vaccines in the EU to be held virtually on 26 March 2021 from 13:00 to 15:15 CET. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the month: Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study)
March 1, 2021For March 2021, we have selected: Lynch D.R. et al. Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study). Ann Neurol 2021; 89:212-225. doi: 10.1002/ana.25934. -
InterviewsEAN News
Prof. Dafin Muresanu, Chair of the EAN Communication Committee, interviews Prof. Raad Shakir, CBE
March 1, 2021Prof. Dafin Muresanu, Chair of the EAN Communication Committee interviews Prof. Raad Shakir, CBE -
Country of the Month for March 2021 is Lithuania
-
EAN NewsEducation cornerEducation
First Virtual EAN Regional Teaching Course in Moscow, Russia
March 1, 2021This year, the EAN Regional Teaching Course also has to adapt to changes. We are happy to announce the first Virtual Regional Teaching Course (RTC in Moscow, Russia 2021 - Virtual - ean.org ) on April 15-17, 2021. -
Clinical Fellowship Reports 2019
-
Breaking newsCOVID-19Research
Assessing brain capillaries in coronavirus disease 2019
February 25, 2021Assessing brain capillaries in coronavirus disease 2019 -
Breaking newsCOVID-19Research
Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US—December 14, 2020-January 18, 2021
February 25, 2021Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US—December 14, 2020-January 18, 2021 -
Breaking newsCOVID-19Research
Effect of high-dose zinc and ascorbic acid supplementation vs usual care on symptom length and reduction among ambulatory patients with SARS-CoV-2 infection. The COVID A to Z randomized clinical trial
February 25, 2021Effect of high-dose zinc and ascorbic acid supplementation vs usual care on symptom length and reduction among ambulatory patients with SARS-CoV-2 infection. The COVID A to Z randomized clinical trial -
Breaking newsCOVID-19Research
Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: a randomized clinical trial
February 25, 2021Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: a randomized clinical trial -
Breaking newsCOVID-19Research
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
February 25, 2021Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial -
Breaking newsCOVID-19Research
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
February 25, 2021Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia -
Breaking newsCOVID-19Research
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
February 25, 2021Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial -
Breaking newsCOVID-19Research
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study
February 25, 2021Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study









